You are here: Industry Insights > Mundipharma

News List

Mundipharma licenses Starpharma’s VivaGel BV biospectrumasia
May 03, 2018
Mundipharma will register and launch VivaGel BV as part of the popular BETADINE range, which is sold in more than 120 countries
Mundipharma CEO maintains position in the Power List biospectrumasia
April 23, 2018
This is the fourth year in succession that Singh has featured among the Power List’s top business leaders.
Mundipharma Expands Santen Ophthalmic Partnership with Saflutan(R) and Taptiqom(R) prnasia
January 30, 2018
Mundipharma expanded its partnership with Santen Pharmaceutical Co. Ltd, a specialty ophthalmic pharmaceutical company
Mundipharma signs Chinese licensing and distribution agreement with Grünenthal pharmafile
January 17, 2018
US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on behalf of Grünenthal, it has emerged.
Grunenthal and Mundipharma enter commercial partnership in China prnasia
January 16, 2018
Grunenthal and Mundipharma announced today that they've entered into a License and Distribution Agreement.
Mundipharma Uses Thinfilm's NFC Solution to Generate Consumer Awareness for New Cold-Prevention Medi prnasia
December 22, 2017
Thin Film Electronics ASA, a global leader in NFC (near field communication) mobile marketing and smart packaging solutions, today announced Mundipharma as a new customer in the OTC (over-the-counter) healthcare market.
Mundipharma to run ophthalmology portfolio distribution for NTC in Middle East and Africa pharmaasia
December 21, 2017
The NTC portfolio Mundipharma will look at addresses several unmet opthalmic medical needs, including blepharitis, dry eye, allergies and glaucoma.
Janssen and Mundipharma sign distribution deal for type 2 diabetes treatments pharmaceufical-technology
September 06, 2017
Vokanamet is approved in the European Union (EU) to improve glycaemic control in adult patients with type 2 diabetes.
Mundipharma launches DIFOLTA for relapsed or refractory Peripheral T-cell Lymphoma pharmaasia
September 06, 2017
DIFOLTA, which comes in 20mg injection solution form, is listed as a preferred second line treatment
Mundipharma launches new treatment for lymphoma biospectrumasia
August 31, 2017
In 2016, Mundipharma filed the approval application for the medicine based on the results both from the Japan study and a global study, which led to marketing authorization, approval and now the launch.

Previous page 1 2 3 4 5 6 Next page